This inventor holds 2 USPTO granted patents, plus 2 CIPO patents and 2 EPO patents. Top assignees: Evonik Operations Gmbh, Evonik Roehm Gmbh. Active years: 2017-2020.
Company Filing History:
Years Active: 2017-2020
Title: Thomas Dassinger: Innovator in Pharmaceutical Coatings
Introduction
Thomas Dassinger is a notable inventor based in Babenhausen, Germany. He has made significant contributions to the field of pharmaceutical and nutraceutical formulations. With a focus on innovative coating compositions, his work has led to the development of patents that enhance the delivery of active ingredients.
Latest Patents
Thomas Dassinger holds 2 patents. His latest patents include "Granules comprising isomaltulose synthase" and "Coating composition suitable for pharmaceutical or nutraceutical dosage forms." The first invention provides granules that incorporate isomaltulose synthase, while the second invention relates to a coating composition that is suitable for pharmaceutical or nutraceutical dosage forms. This coating composition comprises a core with one or more active ingredients and includes at least 20% by weight of an enteric core/shell polymer composition derived from an emulsion polymerization process.
Career Highlights
Throughout his career, Thomas Dassinger has worked with prominent companies such as Evonik Röhm GmbH and Evonik Operations GmbH. His experience in these organizations has allowed him to refine his expertise in the development of pharmaceutical formulations and coatings.
Collaborations
Some of his notable coworkers include Kathrin Nollenberger and Jan Hendrik Schattka. Their collaboration has contributed to the advancement of innovative solutions in the pharmaceutical industry.
Conclusion
Thomas Dassinger's work in the field of pharmaceutical coatings exemplifies the importance of innovation in enhancing drug delivery systems. His patents reflect a commitment to improving health outcomes through advanced formulations.